Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice

Journal of Clinical Investigation

Volumn 119, Issue 3, 2009, Pages 540-550

  Singh, Anurag Kumar ^a   Riederer, Brigitte ^a   Krabbenhöft, Anja ^a   Rausch, Brigitte ^a   Bonhagen, Janina ^a   Lehmann, Ulrich ^a   De Jonge, Hugo R ^b   Donowitz, Mark ^c   Yun, Chris ^d   Weinman, Edward J ^e   Kocher, Olivier ^f   Hogema, Boris M ^b   Seidler, Ursula ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; BETA 2 ADRENERGIC RECEPTOR; BICARBONATE; FORSKOLIN; INTESTINAL ANION; LYSOPHOSPHATIDIC ACID; POSTSYNAPTIC DENSITY PROTEIN 95; REGULATOR PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 2; SODIUM PROTON EXCHANGE PROTEIN 3; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; LYSOPHOSPHOLIPID; PDZK1 PROTEIN, MOUSE; PHOSPHOPROTEIN; SIGNAL PEPTIDE; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER REGULATORY FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; CRYPT CELL; DUODENUM; DUODENUM SECRETION; LASER MICRODISSECTION; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; WILD TYPE; ANIMAL; CELL MEMBRANE; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GENE DELETION; GENETICS; INTESTINE SECRETION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION;

ANIMALS; ANIONS; BICARBONATES; CELL MEMBRANE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DUODENUM; EPITHELIAL CELLS; FORSKOLIN; GENE DELETION; INTESTINAL SECRETIONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOPHOSPHOLIPIDS; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; RECEPTORS, ADRENERGIC, BETA-2; SODIUM-HYDROGEN ANTIPORTER;

EID: 65649117700     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35541     Document Type: Article

References (62)

1. Guggino, W.B. 2004. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins. Proc. Am. Thorac. Soc. 1:28-32.
2. Guggino, W., and Stanton, B. 2006. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat. Rev. Mol. Cell. Biol. 7:426-436.
3. Lamprecht, G., and Seidler, U. 2006. The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. Am. J. Physiol. Gastrointest. Liver Physiol. 291:G766-G777.
4. Li, C., Roy, K., Dandridge, K., and Naren, A.P. 2004. Molecular assembly of cystic fibrosis transmembrane conductance regulator in plasma membrane. J. Biol. Chem. 279:24673-24684.
5. Moyer, B.D., et al. 1999. A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J. Clin. Invest. 104:1353-1361.
6. Moyer, B.D., et al. 2000. The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. J. Biol. Chem. 275:27069-27074.
7. Swiatecka-Urban, A., et al. 2002. PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 277:40099-40105.
8. Raghuram, V., Mak, O.D., and Foskett, J.K. 2001. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. Proc. Natl. Acad. Sci. U. S. A. 98:1300-1305.
9. Wang, S., Yue, H., Derin, R., Guggino, W., and Li, M. 2000. Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell. 103:169-179.
10. Bates, I.R., et al. 2006. Membrane lateral diffusion and capture of CFTR within transient confinement zones. Biophys. J. 91:1046-1058.
11. Haggie, P.M., Stanton, B.A., and Verkman, A.S. 2004. Increased diffusional mobility of CFTR at the plasma membrane after deletion of its C-terminal PDZ binding motif. J. Biol. Chem. 279:5494-5500.
12. Bagorda, A., et al. 2002. Reciprocal protein kinase A regulatory interactions between cystic fibrosis transmembrane conductance regulator and Na+/ H+ exchanger isoform 3 in a renal polarized epithelial cell model. J. Biol. Chem. 277:21480-21488.
13. Ko, S., et al. 2004. Gating of CFTR by the STAS domain of SLC26 transporters. Nat. Cell. Biol. 6:343-350.
14. Li, C., et al. 2007. Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell. 131:940-951.
15. Li, C., et al. 2005. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J. Exp. Med. 202:975-986.
16. Naren, A.P., et al. 2003. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc. Natl. Acad. Sci. U. S. A. 100:342-346.
17. Guerra, L., et al. 2005. Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o- cells and rescues {delta}F508 CFTR functional expression in cystic fibrosis cells. J. Biol. Chem. 280:40925-40933.
18. Wolde, M., et al. 2007. Targeting CAL as a negative regulator of {delta}F508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. J. Biol. Chem. 282:8099- 8109.
19. Dev, K.K. 2004. Making protein interactions druggable: targeting PDZ domains. Nat. Rev. Drug Discov. 3:1047-1056.
20. Kleizen, B., Braakman, I., and de Jonge, H.R. 2000. Regulated trafficking of the CFTR chloride channel. Eur. J. Cell. Biol. 79:544-556.
21. Donowitz, M., et al. 2005. NHERF family and NHE3 regulation. J. Physiol. 567:3-11.
22. Hernando, N., et al. 2005. NaPi-IIa and interacting partners. J. Physiol. 567:21-26.
23. Lamprecht, G., Weinman, E.J., and Yun, C.H. 1998. The role of NHERF and E3KARP in the cAMP-mediated inhibition of NHE3. J. Biol. Chem. 273:29972-29978.
24. Thelin, W.R., Hodson, C.A., and Milgram, S.L. 2005. Beyond the brush border: NHERF4 blazes new NHERF turf. J. Physiol. 567:13-19.
25. Yun, C.H., Lamprecht, G., Forster, D.V., and Sidor, A. 1998. NHE3 kinase A regulatory protein E3KARP binds the epithelial brush border Na+/H+ exchanger NHE3 and the cytoskeletal protein ezrin. J. Biol. Chem. 273:25856-25863.
26. Murtazina, R., et al. 2007. Tissue-specific regulation of sodium/proton exchanger isoform 3 activity in Na+/H+ exchanger regulatory factor 1 (NHERF1) null mice: cAMP inhibition is differentially dependent on NHERF1 and exchange protein directly activated by cAMP in ileum versus proximal tubule. J. Biol. Chem. 282:25141-25151.
27. Wade, J.B., et al. 2003. Localization and interaction of NHERF isoforms in the renal proximal tubule of the mouse. Am. J. Physiol. Cell Physiol. 285:C1494-C1503.
28. Wade, J.B., Welling, P.A., Donowitz, M., Shenolikar, S., and Weinman, E.J. 2001. Differential renal distribution of NHERF isoforms and their colocalization with NHE3, ezrin, and ROMK. Am. J. Physiol. Cell Physiol. 280:C192-C198.
29. Kocher, O., Pal, R., Roberts, M., Cirovic, C., and Gilchrist, A. 2003. Targeted disruption of the PDZK1 gene by homologous recombination. Mol. Cell. Biol. 23:1175-1180.
30. Shenolikar, S., Voltz, J.W., Minkoff, C.M., Wade, J.B., and Weinman, E.J. 2002. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc. Natl. Acad. Sci. U. S. A. 99:11470-11475.
31. Broere, N., et al. 2007. Cystic fibrosis transmembrane conductance regulator activation is reduced in the small intestine of Na+/H+ exchanger 3 regulatory factor 1 (NHERF-1)- but not NHERF-2-deficient mice. J. Biol. Chem. 282:37575-37584.
32. Hillesheim, J., et al. 2007. Down regulation of small intestinal ion transport in PDZK1-(CAP70/NHERF3) deficient mice. Pflugers Arch. 454:575-586.
33. Hogan, D., et al. 1997. Acid-stimulated duodenal bicarbonate secretion involves a CFTR-mediated transport pathway in mice. Gastroenterology. 113:533-541.
34. Seidler, U., et al. 1997. A functional CFTR protein is required for mouse intestinal cAMP-, cGMP- and Ca(2+)-dependent HCO3- secretion. J. Physiol. 505:411-423.
35. Hogan, D.L., et al. 1997. CFTR mediates cAMP- and Ca2+-activated duodenal epithelial HCO3- secretion. Am. J. Physiol. 272:G872-G878.
36. Singh, A.K., et al. 2008. CFTR and its key role in in vivo resting and luminal acid-induced duodenal HCO3- secretion. Acta. Physiol. (Oxf.). 193:357-365.
37. Ameen, N., Alexis, J., and Salas, P. 2000. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem. Cell. Biol. 114:69-75.
38. Sun, F., et al. 2000. E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells. J. Biol. Chem. 275:29539-29546.
39. Hall, R.A., et al. 1998. A C-terminal motif found in the beta(2)-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc. Natl. Acad. Sci. U. S. A. 95:8496-8501.
40. Li, C.Y., and Naren, A.P. 2005. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners. Pharmacol. & Ther. 108:208-223.
41. Minkoff, C., Shenolikar, S., and Weinman, E.J. 1999. Assembly of signaling complexes by the sodium-hydrogen exchanger regulatory factor family of PDZ-containing proteins. Curr. Opin. Nephrol. Hypertens. 8:603-608.
42. Benharouga, M., et al. 2003. The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia. J. Biol. Chem. 278:22079-22089.
43. Li, J.Q., Dai, Z.P., Jana, D., Callaway, D.J.E., and Bu, Z.M. 2005. Ezrin controls the macromolecular complexes formed between an adapter protein Na+/H+ exchanger regulatory factor and the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 280:37634-37643.
44. Knowles, M.R., Paradiso, A.M., and Boucher, R.C. 1995. In-vivo nasal potential difference - techniques and protocols for assessing efficacy of gene-transfer in cystic-fibrosis. Hum. Gene Ther. 6:445-455.
45. Beck, S., et al. 1999. Lack of correlation between CFTR expression, CFTR Cl- currents, amiloride-sensitive Na+ conductance, and cystic fibrosis phenotype. Pediatr. Pulmonol. 27:251-259.
46. Hofmann, T., et al. 1998. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis. Am. J. Respir. Crit. Care. Med. 157:1844-1849.
47. Ruckes-Nilges, C., et al. 1999. Minor role of Cl-secretion in non-cystic fibrosis and cystic fibrosis human nasal epithelium. Cell. Physiol. Biochem. 9:1-10.
48. Strong, T.V., Boehm, K., and Collins, F.S. 1994. Localization of cystic-fibrosis transmembrane conductance regulator messenger-Rna in the human gastrointestinal-tract by in-situ hybridization. J. Clin. Invest. 93:347-354.
49. Flemstrom, G., Safsten, B., and Jedstedt, G. 1993. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology. 104:825-833.
50. Glavin, G.B., and Szabo, S. 1990. Dopamine in gastrointestinal disease. Dig. Dis. Sci. 35:1153-1161.
51. Zhang, X.H., et al. 2008. beta-Adrenoceptors, but not dopamine receptors, mediate dopamine-induced ion transport in late distal colon of rats. Cell Tissue Res. 334:25-35.
52. Tian, Y.M., et al. 2008. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. Neuroscience. 153:634-644.
53. Favia, M., et al. 2006. NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions. Biochem. Biophys. Res. Commun. 347:452-459.
54. Zimmermann, C., et al. 2005. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab. Dispos. 33:219-224.
55. Rossmann, H., et al. 2005. The CFTR associated protein CAP70 interacts with the apical Cl-/HCO3-exchanger DRA in rabbit small intestinal mucosa. Biochemistry. 44:4477-4487.
56. Thomson, R.B., et al. 2005. Role of PDZK1 in membrane expression of renal brush border ion exchangers. Proc. Natl. Acad. Sci. U. S. A. 102:13331-13336.
57. Seidler, U., et al. 2008. Sodium and chloride absorptive defects in the small intestine in Slc26a6 null mice. Pflugers. Archiv. 455:757-766.
58. Lamprecht, G., et al. 2002. The down regulated in adenoma (dra) gene product binds to the second PDZ domain of the NHE3 kinase a regulatory protein (E3KARP), potentially linking intestinal Cl-/ HCO3- exchange to Na+/H+ exchange. Biochemistry. 41:12336-12342.
59. Bakker, A.J., Head, S.I., Wareham, A.C., and Stephenson, D.G. 1998. Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers. Am. J. Physiol. 274:C1718-C1726.
60. Broere, N., et al. 2008. Defective jejunal and colonic salt absorption and altered Na(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice. Pflugers Arch. doi:10.1007/s00424-008-0579-1.
61. Cinar, A., et al. 2007. NHE3 inhibition by cAMP and Ca2+ is abolished in PDZ-domain protein PDZK1-deficient murine enterocytes. J. Physiol. 581:1235-1246.
62. Zhu, W.Z., et al. 2005. Heterodimerization of beta1-and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Circ. Res. 97:244-251.